Tag: weight-loss drugs

Market News

Why Lilly’s Obesity Pill Miss Shook Investors

Lilly's stock crashed after its obesity pill trial fell short. What went wrong, and what’s next for the weight-loss drug...

07/08/2025

4 views

Read More

Market News

Hims & Hers Stock Dips: GLP-1 Sales Miss Expectations

Hims & Hers stock plummets as GLP-1 sales falter. Regulatory pressures mount, but what's next for telehealth's weight-loss boom? Click...

05/08/2025

2 views

Read More

Global Markets

Generic Weight-Loss Drugs: A Game-Changer By 2026

Could generic weight-loss drugs change lives by 2026? A major Indian pharma company is betting big on affordable semaglutide, but...

24/07/2025

3 views

Read More

Growth Picks

$1,000 in Hims & Hers at IPO: Value Today

A $1,000 bet on Hims & Hers at its IPO could be worth a fortune today. Curious about its explosive...

06/05/2025

0 views

Read More

Market News

Hims & Hers Soars With Novo Nordisk Wegovy Deal

Hims & Hers stock skyrockets 27% with Novo Nordisk's Wegovy deal. What’s driving this telehealth surge, and is it time...

29/04/2025

0 views

Read More

Growth Picks

Should You Invest In Weight-Loss Drug Stocks?

Weight-loss drugs are shaking up markets, promising huge profits. But are they a safe bet for your portfolio? Dive into...

29/04/2025

0 views

Read More

Market News

Telehealth Revolutionizes Affordable Weight-Loss Care

Telehealth is slashing weight-loss drug costs, making treatments like Wegovy affordable. How is this changing lives? Click to find out...

29/04/2025

0 views

Read More

Global Companies

Roche’s $50B US Investment: A Pharma Game-Changer

Roche’s $50B US investment is shaking up pharma with new jobs and cutting-edge facilities. But what’s driving this bold move?...

22/04/2025

0 views

Read More

Stocks

Eli Lilly’s Obesity Pill: Stock Surge Insights

Eli Lilly's new obesity pill sent shares soaring. Can it dominate the weight-loss market, or will rivals catch up? Click...

17/04/2025

0 views

Read More